Insider Transactions
Date | Name | Title | Type | Filing | Shares Traded | Price Range | Total Held |
---|---|---|---|---|---|---|---|
Jun 15, 2020 | Director, Chief Operating Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 9,089 | $11.14 | 338,764 | |
Jun 15, 2020 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | $5.13 | 920,186 | |
Jun 15, 2020 | Director, Chairman & CEO | Open market or private sale of non-derivative or derivative security | Form 4 | 20,000 | $10.88 | 900,186 | |
Jun 15, 2020 | Director, Chairman & CEO | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 163 | $11.14 | 900,023 | |
Jun 15, 2020 | Director, Chairman & CEO | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | Form 4 | 20,000 | -- | 102,485 | |
Jun 15, 2020 | Chief Science Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 1,446 | $11.14 | 520,807 | |
Jun 15, 2020 | Chief Financial Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 1,046 | $11.14 | 194,179 | |
Jun 15, 2020 | Chief Legal Officer | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | Form 4 | 662 | $11.14 | 195,169 | |
Jun 16, 2020 | Principal Accounting Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 2,932 | $12.95 | 17,135 | |
Jun 17, 2020 | Chief Medical Officer | Open market or private sale of non-derivative or derivative security | Form 4 | 1,904 | $13.47 | 163,204 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.